![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Cancer Screening Capsule Cleared for Marketing in Israel
Cancer Screening Capsule Cleared for Marketing in Israel
September 5, 2018
Israel’s Ministry of Health granted Check-Cap marketing approval for its C-Scan capsule for colorectal cancer (CRC) screening.
The ingestible capsule, which received the CE Mark in January, gives physicians structural information about the endoluminal surface of the patient’s colon.
The product can be used for screening CRC in patients at average risk for the disease who cannot or do not wish to receive a colonoscopy.
Upcoming Events
-
21Oct